Life ScienceCompany
Juniper Pharmaceuticals M&A Summary
Juniper Pharmaceuticals has acquired 1 company of its own.
Juniper Pharmaceuticals’ largest acquisition to date was in 2013, when it acquired Molecular Profiles for $25M. The Company’s most targeted sectors include life science (100%).
Juniper Pharmaceuticals Ownership
Who owns Juniper Pharmaceuticals?
Juniper Pharmaceuticals is owned by Catalent. It was acquired on July 3, 2018.
Juniper Pharmaceuticals Business Overview
Where is Juniper Pharmaceuticals headquartered?
Juniper Pharmaceuticals is headquartered in Boston, Massachusetts.
What is Juniper Pharmaceuticals’ revenue?
Juniper Pharmaceuticals disclosed revenue of 50M USD for 2017 and 55M USD for 2016.
How many employees does Juniper Pharmaceuticals have?
Juniper Pharmaceuticals has 105 employees.
What sector is Juniper Pharmaceuticals in?
Juniper Pharmaceuticals is a life science company.
When was Juniper Pharmaceuticals founded?
Juniper Pharmaceuticals was founded in 1986.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
Unlimited Searches
